Nonvisualized Gallbladder After Roux-en-Y Bypass
A 54-year-old woman presents with 36 hours of right upper quadrant pain, nausea, and fever of 38.4°C. WBC is 14.8 × 10^9/L; total bilirubin 1.1 mg/dL; ALP 130 U/L; AST 55 U/L; ALT 48 U/L; lipase 30 U/L. Ultrasound shows cholelithiasis without gallbladder wall thickening or pericholecystic fluid. She had a Roux-en-Y gastric bypass 6 years ago and takes hydromorphone 4 mg every 6 hours for chronic back pain. Hepatobiliary scintigraphy is performed with 5 mCi Tc-99m mebrofenin. At 60 minutes, hepatic uptake is prompt and there is clear excretion into the bowel, but the gallbladder is not visualized. Image quality is good, and the patient's pain is unchanged during the study. The referring surgeon asks whether this confirms acute cholecystitis and whether to operate tonight.
1. How do you interpret the 60-minute study, and what is the differential for a nonvisualized gallbladder with bowel activity in this patient?
Read the worked answer
A nonvisualized gallbladder with preserved hepatic uptake and bowel excretion is abnormal and raises concern for cystic duct obstruction, but it does not by itself confirm acute cholecystitis. The differential includes acute cholecystitis, chronic cholecystitis with a nonfunctioning gallbladder, prolonged fasting, opioid-induced sphincter of Oddi contraction, and altered biliary anatomy after Roux-en-Y bypass. The 60-minute time point may be too early in a patient with a dilated or ectopic gallbladder. Given the fever, leukocytosis, and sonographic gallstones without wall thickening, the pretest probability is moderate rather than high. The appropriate next step is delayed imaging, usually to 4 hours, with or without morphine augmentation, before the surgeon commits to overnight surgery on the basis of a single 60-minute image.
2. What is the role of morphine augmentation here, and what dose, timing, and contraindications would you consider?
Read the worked answer
Morphine augmentation increases sphincter of Oddi tone, promotes gallbladder filling, and can shorten the study in patients whose gallbladder is not seen at 60 minutes. A typical dose is 0.04 mg/kg intravenously over 3 minutes, with imaging continued for 30 minutes; if the gallbladder remains nonvisualized, the study is positive. Contraindications include known morphine allergy, acute pancreatitis, and high-grade biliary obstruction. In this patient, the chronic hydromorphone use is a caveat: the sphincter may already be contracted, and augmented filling may be less reliable, so a negative response is less reassuring. Because she has a history of Roux-en-Y bypass, the anatomy may also make gallbladder filling atypical. Delayed imaging without morphine is a reasonable alternative if the clinician is concerned about confounding.
3. If the gallbladder remains nonvisualized at 4 hours, how does that change management, and what else would you want the surgeon to know?
Read the worked answer
Persistent nonvisualization at 4 hours increases the likelihood of cystic duct obstruction and supports acute cholecystitis, but it is not perfectly specific, especially with chronic opioid use and prior bypass surgery. The surgeon should integrate the scan with the clinical picture, the ultrasound, and the patient's surgical risk. A positive scan in a febrile, leukocytopenic patient with gallstones is enough to discuss urgent cholecystectomy, but the decision should not rest on the scan alone. The surgeon should also know that the scan was performed with mebrofenin, that the patient is on chronic opioids, and that the gallbladder may be ectopic or chronically nonfunctioning. If the diagnosis remains uncertain, repeat ultrasound, CT, or surgical consultation is preferable to treating the scan as definitive.